AXNA vs NP5: Side-by-Side Comparison
Compare Amplifon S.p.A (AXNA) and NEWRON PHARMACEUT. EO-20 (NP5) side by side: market cap EUR 2.62B vs EUR 281.92M. Financials, growth and model signals on Bullrun.
| Metric | AXNA | NP5 |
|---|---|---|
| Company | Amplifon S.p.A | NEWRON PHARMACEUT. EO-20 |
| Country / Exchange | Italy · F | Italy · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Distribution | Biotechnology |
| Market cap | EUR 2.62B | EUR 281.92M |
| P/E ratio | 31.8 | — |
| Dividend yield | 2.94% | — |
| Valuation model | 28.1% overvalued | — |
| Revenue (FY2025) | EUR 2.40B | EUR 19.13M |
| Revenue growth YoY | -0.6% | -62.8% |
| Net income | EUR 91.55M | EUR -13.24M |
| Gross margin | — | — |
| Diluted EPS | 0.40 | -0.66 |